Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaski

Showing results (891-900 of 1,021) with videos related to

Pageof 103
Sort By:
European Heart Journal|March 19, 2014
Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)Nishat Siddiqi, Christopher Neil, Margaret Bruce, et al.
Health Technology Assessment (Winchester, England)|February 27, 2010
The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision modelH Hemingway, M Henriksson, R Chen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Frontiers in Pediatrics|June 27, 2022
Cardiac Manifestations of Myotonic Dystrophy in a Pediatric CohortLaia Brunet Garcia, Ankita Hajra, Ella Field, et al.
European Heart Journal|March 6, 2026
Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaquesDuk-Woo Park, William E Boden, Raffaele De Caterina, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
BMJ (Clinical Research Ed.)|January 21, 2010
Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgeryMartin Henriksson, Stephen Palmer, Ruoling Chen, et al.
Mbio|February 13, 2020
Plasmids Shaped the Recent Emergence of the Major Nosocomial Pathogen Enterococcus faeciumS Arredondo-Alonso, J Top, A McNally, et al.
Circulation|August 30, 2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
International Journal of Cardiology|October 29, 2022
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and managementMichele Brignole, Franco Cecchi, Aris Anastasakis, et al.
Pageof 103

Showing results (891-900 of 1,021) with videos related to

Sort By:
Pageof 103
European Heart Journal|March 19, 2014
Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)Nishat Siddiqi, Christopher Neil, Margaret Bruce, et al.
Health Technology Assessment (Winchester, England)|February 27, 2010
The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision modelH Hemingway, M Henriksson, R Chen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Frontiers in Pediatrics|June 27, 2022
Cardiac Manifestations of Myotonic Dystrophy in a Pediatric CohortLaia Brunet Garcia, Ankita Hajra, Ella Field, et al.
European Heart Journal|March 6, 2026
Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaquesDuk-Woo Park, William E Boden, Raffaele De Caterina, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
BMJ (Clinical Research Ed.)|January 21, 2010
Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgeryMartin Henriksson, Stephen Palmer, Ruoling Chen, et al.
Mbio|February 13, 2020
Plasmids Shaped the Recent Emergence of the Major Nosocomial Pathogen Enterococcus faeciumS Arredondo-Alonso, J Top, A McNally, et al.
Circulation|August 30, 2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
International Journal of Cardiology|October 29, 2022
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and managementMichele Brignole, Franco Cecchi, Aris Anastasakis, et al.
Pageof 103